PFE

Pfizer, Inc.

52.43
USD
2.93%
52.43
USD
2.93%
38.93 61.71
52 weeks
52 weeks

Mkt Cap 292.46B

Shares Out 5.58B

Chat
Send me real-time posts from this site at my email

List of Best Biotech Stocks to Buy in 2022

Biotechnology is the study of living creatures, biological systems, or derivatives to develop and/or improve healthcare products and therapies. This technology is connected with medical and pharmaceuticals, genomics, and food and chemical manufacturing. According to Precedence Research, the biotechnology market size is expected to surpass around US$ 1,683.52 billion by 2030 and expand growth at a CAGR of 8.7% from 2021 to 2030. What are the Growth Drivers of Biotechnology? The growing instances of chronic diseases are one of the major drivers of the growth of the biotech sector. The bio-pharmacy segment is contributing towards the prevention of chronic diseases and is focusing on personalized treatment plans. In addition to it, the new cell therapy concepts are also being introduced which has further driven the industry growth. What are the Challenges Faced by the Biotech Companies? User-friendly tools are essential for bioinformatics platform utilization. And many bioinformatics applications require significant computer knowledge. Therefore, equipment and implementation costs are very high in the industry. In addition to high equipment costs, this industry has large-scale data of patients. Since medical data is confidential, the management of this huge scale data is very important and currently a challenge for the industry. Also, with such large-scale data, analysis is required to better understand and develop relevant technologies in the future. Therefore, the data of the biotech sector is extremely valuable. The Opportunities for the Biotech Sector The development of innovative techniques to treat diseases is very crucial for the biotechnology market. More and more r412esearch and the ongoing technological advancements are excellent opportunities for growth for this sector. The pandemic has created an abundance of opportunities for the biotech sector. Especially those who are engaged in the treatment and development of the COVID-19 vaccine. Hence a wise investment decision would be to seek COVID-19 vaccine companies with successful drugs in the market and/or pipeline. Many leading biotech companies are winning the biotech market with highly demanding drugs already in the market and strong drugs in pipelines. Here we have compiled some of the best biotech stocks to buy in 2022: Johnson and Johnson Johnson & Johnson is one of the oldest pharmaceutical companies. It engages in the research and development, manufacture, and sale of products in the health care field. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. Johnson & Johnson maintains operations in 60 countries, while its roughly 250 subsidiaries and their products are sold in more than 175 countries. Johnson and Johnson recently announced its fourth-quarter and full-year results of 2021. Total sales of $93.8 billion were reported, representing a 13.6% growth. Net income was reported to be $20.9 billion, representing a 42% increase Earnings per share were reported at $7.81 Disclaimer: Futures, options, and over the counter foreign exchange products may involve substantial risk and may not be suitable for all investors. Leverage can work against you as well as for ... more

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue